A veteran's metastatic prostate cancer diagnosis highlights the importance of PSA screening, early detection and informed ...

As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to ...

SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new ...

Chinese researchers have built a machine-learning nomogram that combines biparametric MRI radiomics, clinical variables, and ...

The number of men diagnosed with prostate cancer in England surged by almost 4,000 in just one year, a major national audit ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine and SOPHiA GENETICS (NASDAQ: SOPH) today announce a collaboration to advance new prostate ...

CHAPS, the leading prostate screening charity, is holding a unique workshop aiming to tackle the conflicting messages men are ...

I reject the idea that a man who keeps every prostate cancer surveillance appointment has ‘untreated cancer,’” writes Howard ...

Prostate cancer rates in young men across England have nearly quadrupled over the past two decades, concerning new research ...

A prospective study shows PSMA PET/CT-guided targeted biopsy detects clinically significant prostate cancer in 37 percent of ...

Androgen deprivation therapy (ADT) can be an effective treatment for men diagnosed with prostate cancer. By blocking testosterone, the therapy can slow or stop the cancer, contributing to a disease ...